SCM wins new Sanofi fill/finish deal

Isolator at SCM's facility
Isolator at SCM's facility

Related tags Scm pharma United kingdom Contract Cancer

SCM Pharma wins another deal with French drug giant Sanofi-Aventis.

Under the new agreement, financial terms of which were not disclosed, the UK contract manufacturing organisation (CMO) will fill and finish a candidate cancer drug for Phase III trials.

SCM completed the first stage of the project earlier this year​ and, according to Sanofi, the CMO’s ability to meet tight deadlines was key to it winning the new contract.

The Paris firm said it had been: “Very impressed with the manner and speed in which SCM Pharma was able to deliver the project last year,” adding that “Based on its performance, we had no hesitation in approaching and appointing SCM Pharma with another project​.”

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Webinars

Headlines